Protease Inhibitors
Showing 1 - 25 of 4,930
Protease Inhibitors in Chronic Hepatitis C
Completed
- Chronic Hepatitis C
-
Graz, AustriaDepartment of Internal Medicine, Medical University of Graz
Jan 11, 2023
HIV Patients Trial in France (No intervention)
Completed
- HIV Patients
- No intervention
-
Créteil, France
- +5 more
Jul 30, 2021
HIV, Cardiovascular Diseases, Hypertension Trial in United States (Indinavir sulfate, Ritonavir, Amlodipine)
Completed
- HIV Infections
- +2 more
- Indinavir sulfate
- +3 more
-
San Francisco, California
- +8 more
Oct 28, 2021
HIV Trial in United States (Pravastatin sodium, Simvastatin, Atorvastatin calcium)
Completed
- HIV Infections
- Pravastatin sodium
- +5 more
-
Los Angeles, California
- +12 more
Oct 27, 2021
HIV-1 Infection Trial (Doravirine, Tenofovir, Lamivudine, Baseline regimen of ritonavir- or cobicistat-boosted protease
Active, not recruiting
- HIV-1 Infection
- Doravirine, Tenofovir, Lamivudine
- +4 more
- (no location specified)
Sep 2, 2022
HIV-1-infection, Multi-Antiviral Resistance Trial in Milan (REGISTER CREATION)
Recruiting
- HIV-1-infection
- Multi-Antiviral Resistance
- REGISTER CREATION
-
Milan, MI, ItalyOspedale San Raffaele
Dec 22, 2021
HIV I Infection, Adiposity Trial in Saint Louis (Frequently sampled glucose tolerance testing, abdominal subcutaneous adipose
Recruiting
- HIV I Infection
- Adiposity
- Frequently sampled glucose tolerance testing
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Jun 15, 2022
HIV-1-infection Trial in Worldwide (Dolutegravir & Rilpivirine 2 drug fixed dose combined therapy)
Active, not recruiting
- HIV-1-infection
- Dolutegravir & Rilpivirine 2 drug fixed dose combined therapy
-
Antwerp, Belgium
- +28 more
May 23, 2022
HIV Trial in Aurora (Atazanavir)
Completed
- HIV
-
Aurora, ColoradoUniversity of Colorado Denver and Health Sciences Center
Oct 31, 2019
HIV-1 Infection Trial in Badalona (Isentress® (Raltegravir, 400 mg every 12 hours), Isentress® (Raltegravir, 400 every 12
Completed
- HIV-1 Infection
- Isentress® (Raltegravir, 400 mg every 12 hours)
- Isentress® (Raltegravir, 400 every 12 hours)
-
Badalona, Barcelona, SpainGermans Trias i Pujol Hospital
Nov 11, 2019
HIV Trial in Puerto Rico, United States (Indinavir sulfate, Abacavir sulfate, Amprenavir)
Completed
- HIV Infections
- Indinavir sulfate
- +7 more
-
Los Angeles, California
- +44 more
Oct 27, 2021
HIV, Fenofibrate, Protease Inhibitors Trial run by the CC (Fenofibrate, Ritonavir, Lopinavir/Ritonavir)
Completed
- HIV
- +4 more
- Fenofibrate
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 6, 2019
COVID-19 Trial in Minneapolis (Shionogi Protease Inhibitor (S-217622), )
Recruiting
- COVID-19
- Shionogi Protease Inhibitor (S-217622)
- placebo
-
Minneapolis, MinnesotaUniversity of Minnesota
Jan 12, 2023
Malaria, HIV Trial in Tororo (Lopinavir/ritonavir, Efavirenz, Zidovudine)
Completed
- Malaria
- HIV Infections
- Lopinavir/ritonavir
- +3 more
-
Tororo, UgandaTororo District Hospital
Apr 19, 2019